• Preguntas frecuentes
  • Glosario
Cerrar

Preguntas frecuentes

Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

Ver todas las preguntas frecuentes

Cerrar

Glosario

Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial

Ver el glosario completo

ATMP Engage PPI Directory

The PPI Directory contains patient and public involvement (PPI) resources for developers of cell and gene therapies, including toolkits, guidelines, advice, templates and case studies.

PPI Directory

PPI Themes
Research Field
Organisation Type
Development Stage
Audience
Country
Content Type
    Showing 5 of 168 results.
    Page 18 of 34
    2016

    PREFER patient preferences project

    PREFER project by European Patient Forum (EPF)
    View this Resource

    Research Field

    • General

    Organisation Type

    • Third Sector/Charity

    Development Stage

    • Identifying/Prioritising Patient Need
    • Research and Clinical Development
    • Regulatory Approval
    • Health Technology Assessment
    • Service Delivery

    Audience

    • Researchers/Developers
    • Industry

    Country

    • Europe

    Content Type

    • Resource
    2020

    Health Outcomes Observatory (H2O) project

    Project by European Patient Forum (EPF)
    View this Resource

    Research Field

    • General
    • Biomedical Lab
    • Pharmaceutical

    Organisation Type

    • Third Sector/Charity

    Development Stage

    • Identifying/Prioritising Patient Need
    • Research and Clinical Development

    Audience

    • Researchers/Developers
    • Public/Patients
    • Charity Sector
    • Industry

    Country

    • Europe

    Content Type

    • Resource
    2014

    Revised framework for interaction between the European Medicines Agency and patients and consumers and their organisations

    Generic PPI framework by the European Medicines Agency
    Visit this Resource

    Research Field

    • Other

    Organisation Type

    • Regulatory Body

    Development Stage

    • Regulatory Approval

    Audience

    • Researchers/Developers
    • Public/Patients

    Country

    • Europe

    Content Type

    • Resource
    2020

    EMA Regulatory Science to 2025 - strategic reflection

    Report reflecting on the EMA's regulatory framework by the European Medicines Agency
    View this Resource

    Research Field

    • Other

    Organisation Type

    • Regulatory Body

    Development Stage

    • Regulatory Approval

    Audience

    • Researchers/Developers
    • Public/Patients

    Country

    • Europe

    Content Type

    • Resource

    Advanced Therapy Classification

    Classification of ATMPs by the European Medicines Agency
    Visit this Resource

    Research Field

    • ATMP/Gene Therapy Development

    Organisation Type

    • Regulatory Body

    Audience

    • Researchers/Developers
    • Public/Patients
    • Charity Sector
    • Industry
    • Other groups

    Country

    • Europe

    Content Type

    • Resource
    Volver arriba